AzTrials
AzTrials

Respiratory InsufficiencyIPINCT01795196

Integrated Pulmonary Index (IPI) as a Determinate of Weaning Success and/or Failure in the Pediatric Population

An observational study of Respiratory Insufficiency, run by Rush University Medical Center at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Integrated pulmonary index (IPI) is a tool that monitors respiratory status. It takes into account four parameters: respiratory rate, end-tidal CO2, heart rate and O2 saturation using a pulse oximeter and specialized sidestream CO2 monitor. Read more about this study

Who is it for?
Ages 1 year to 18 years
Conditions the study is for
Respiratory Insufficiency
How many people
0 participants
Where
1 siteUnited States
Study dates
May 2011to 15 Sep 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Mechanically ventilated pediatric patients undergoing the weaning process.

Who may be able to join

  • Intubated at least 24 hours
  • Less than 18 years of age
  • Greater than 1 year of age
  • Enrollment will be stratified based upon the time a potential subject has received MV.

Who cannot join

  • Patients less than 1 year of age
  • Presence of a tracheostomy tube

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Rush University Medical Center- Rush Children's Hospital

    Chicago, Illinois, 60612

Other trials in United States

About this study

Official title: The Use of Integrated Pulmonary Index (IPI) as a Determinate of Weaning Success and/or Failure in the Pediatric Population

Integrated pulmonary index (IPI) is a tool that monitors respiratory status. It takes into account four parameters: respiratory rate, end-tidal CO2, heart rate and O2 saturation using a pulse oximeter and specialized sidestream CO2 monitor. The device can continuously monitor and display the patient's ventilatory state as a single digit, 1-10. In addition, trends can be kept and it can provide early indication of changes in respiratory status. IPI has only been studied in pediatric patients who are under sedation; however, more uses for the monitoring tool are a possibility. One of those possibilities is to use IPI to monitor pediatric patients during the weaning and extubation process to determine if a specific number, or less than a specific number, is associated with extubation failure. Therefore, clinicians and physicians would be better able to determine if the patient is ready for extubation.

Read the detailed description

This is an prospective observational study designed to collect data on the IPI in mechanically ventilated pediatric patients undergoing the weaning process and extubation using the FDA approved Capnostream 20® bedside monitor (CS20) (Covidien Inc., Mansfield, MA, USA). Inclusion criteria include patients intubated at least 24 hours who are less than 18 years of age but greater than 1 year of age. Exclusion criteria include patients less than 1 year of age or the presence of a tracheostomy tube. The IPI number will be blinded throughout the study but directly monitored values (SpO2, HR, PETCO2, RR) will be available for clinical use.

Upon meeting inclusion criteria, the subject will be given a code number to protect their identity. Study personnel will verify that the CS20 monitor matches the institutional time/date prior to use and the de-identified subject ID will be entered in the CS20 monitor. The subject will be connected to the CS20 device via a pulse oximeter probe and a CO2 sampling line attached to the ventilator circuit, both are standard of care in monitoring ventilated pediatric patients. Subjects will be monitored for 10 minutes prior to the initiation of physician directed weaning evaluation or extubation. Study personnel will verify that the IPI number on the monitor is not visible to clinicians in order to prevent changes on routine interventions.

Investigators will record date, time, and mechanical ventilator settings when the CS20 monitor is started to collect baseline data. Physician directed weaning trials or ventilator changes to test readiness for extubation will be recorded to correlate IPI values at a later date. Venous and/or arterial blood gas (ABG) data and nebulizer treatments occurring during the study will be recorded along with the PETCO2 when the ABG is drawn or nebulizer treatment administered and CS20 monitor will be marked with an event. For nebulizer treatments, mark event and also push the pump off button to pause IPI monitoring for 15 minutes in order to prevent sample line from becoming clogged. CS 20 IPI monitoring will automatically resume 15 minutes after pausing the pump. If the weaning trial is stopped or the patient is extubated, the date and time will be recorded and the monitor will be marked with an event. Subjects that fail the weaning readiness determination will have the process repeated for up to three weaning attempts. If not weaned from mechanical ventilation after the third attempt, participation in the trial will be terminated. Participation in the study will be terminated if extubation does not occur within 72 hours of enrollment.

If extubated, the event will be marked on the monitor and the date and time will be recorded on the case report form (CRF). After extubation, the subject will remain reconnected to the CS20 monitor via a PETCO2 sampling nasal cannula capable of providing supplemental oxygen and a pulse oximeter. Subjects will continue to be monitored for up to 48 hours post extubation or until transferred out of the ICU. If a subject fails extubation and requires re-intubation or use of noninvasive ventilation, the event and time will be recorded and the study will be terminated. The subject may withdraw from the study at anytime or the attending physician may terminate their participation in the trial.

Necessary protected health information (PHI) includes subject name and medical record number to track the subject at 48 hours post extubation. PHI will be maintained on a site enrollment log separate from any collected data in a locked file cabinet.

Quantitative data for this study will include the time stamped electronic parameter data by subject ID from the CS20; the CRF with de-identified demographic information, significant pulmonary medical history, ventilator parameters prior to extubation, method used to determine readiness to discontinue mechanical ventilation, number of days on mechanical ventilator, rapid shallow breathing index, VD/VT, ABG and co-morbidity, date and time of extubation and 48 hour post extubation status.

Time stamped electronic parameter data from the CS20 will be obtained from the monitor via a USB drive. Data from the CS20 will be stored in a secure computer by subject ID number. The de-identified subject demographic information, medical and pulmonary history will be obtained from the subject's electronic medical record by the study staff and recorded on the CRF. The CRFs will be stored in a Study Binder in a locked filling cabinet in the College of Sciences. The Study Binder will be stored in a secure location and the data will be retained for three years.

Keywords
pediatric extubation failure, weaning, integrated pulmonary index, mechanical ventilation, extubation readiness, respiratory monitoring tool, Endotracheal Extubation, Pediatric Intensive Care Unit, Rapid Shallow Breathing Index, Physiologic Deadspace
Medical subject headings
Respiratory Insufficiency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To determine if IPI predicts extubation success.

    The IPI number will be compared to extubation success or failure to evaluate the usefulness of the IPI as a predictor.

    Measured: 48 hours post extubation

Secondary outcomes (2)
  1. To compare IPI to RSBI and VD/VT.

    To compare the rapid shallow breathing index (RSBI), physiologic dead space (VD/VT), and IPI as predictors of extubation success and / or failure in the pediatric population.

    Measured: Measured prior to extubation

  2. To assess is there is a correlation between PaCO2 and PetCO2.

    The values will be measured simultaneously to assess strength of correlation. To evaluate the correlation between PaCO2 in the pediatric population.

    Measured: Measured with each blood gas drawn

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2013 (estimated)
  2. Study startMay 2011
  3. Primary completion15 Sep 2017
  4. Study completion15 Sep 2017

Why it stopped: Lack of subjects to participate

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01795196
Sponsor's protocol ID
10110203-IRB01
Acronym
IPI
Status last verified
Dec 2022
First submitted
13 Feb 2013
Last updated
28 Dec 2022
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Respiratory Insufficiency, run by Rush University Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 28 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To determine if IPI predicts extubation success. (time frame: 48 hours post extubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Dec 2022; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in